Cite
HARVARD Citation
Gorst‐Rasmussen, A. et al. (2016). Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care†. Pharmacoepidemiology and drug safety. 25 (11), pp. 1236-1244. [Online].